N-Pharma is a Japanese pharmaceutical company facing economic and environmental challenges. High R&D costs have led to expensive drug prices, reducing demand during economic downturns when people cannot afford medications and opt for generics instead. While low inflation has helped N-Pharma succeed in Japan compared to Europe, cash flow issues and a reliance on the stock market make their business challenging to sustain. Environmental factors like pollution increasing health issues and natural disasters in Japan also threaten N-Pharma's operations and profits.
N-Pharma is a Japanese pharmaceutical company facing economic and environmental challenges. High R&D costs have led to expensive drug prices, reducing demand during economic downturns when people cannot afford medications and opt for generics instead. While low inflation has helped N-Pharma succeed in Japan compared to Europe, cash flow issues and a reliance on the stock market make their business challenging to sustain. Environmental factors like pollution increasing health issues and natural disasters in Japan also threaten N-Pharma's operations and profits.
N-Pharma is a Japanese pharmaceutical company facing economic and environmental challenges. High R&D costs have led to expensive drug prices, reducing demand during economic downturns when people cannot afford medications and opt for generics instead. While low inflation has helped N-Pharma succeed in Japan compared to Europe, cash flow issues and a reliance on the stock market make their business challenging to sustain. Environmental factors like pollution increasing health issues and natural disasters in Japan also threaten N-Pharma's operations and profits.
N-Pharma is a Japanese pharmaceutical company facing economic and environmental challenges. High R&D costs have led to expensive drug prices, reducing demand during economic downturns when people cannot afford medications and opt for generics instead. While low inflation has helped N-Pharma succeed in Japan compared to Europe, cash flow issues and a reliance on the stock market make their business challenging to sustain. Environmental factors like pollution increasing health issues and natural disasters in Japan also threaten N-Pharma's operations and profits.
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 5
Case study:
N-Pharma
Economic & Environmental
Economic
Economic boom in Japan market expansion/more outlets
decreasing rate of employment and other countries High cost of R&D The price of drugs is relatively expensive During economic difficulties the price of the drugs increase many people cant afford to purchase it people tend to buy generic drugs demand for N-Pharmas products is income elastic. Income elasticity of the drugs means that there will be less demand for the drugs as incomes are falling.
Economic
In Japan, the rate of inflation is lower than in Europe
Thus, market in Japan is more success compared than in Europe.
Government provide subsidy enable N-Pharma to
expand their market globally.
Poor cash flow and liquidity problem cause their
business becomes more challenging.
N-Pharma shares traded on the Tokyo stock exchange
Shareholders have traditionally been happy tom invest in N-Pharma, regarding the shares as a relatively risk-free, safe investment.
Economic
Australian citizens already have a high
standard living, they dont want any financial incentive The profit gain by N-pharma can be used to run their business better.
Environmental
Increase in pollution cause people to rely on
medication to stay healthy. Flood/Tsunami in Japan might cause major loss to the business. Geographical location Urban area is better than Rural area. Customers in urban area can afford their products.